세계의 양전자 방사 단층촬영(PET)용 방사성 트레이서 시장 보고서(2024년)

Positron Emission Tomography (PET) Radiotracer Global Market Report 2024

US $ 5,000 ￦ 7,234,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,500 ￦ 10,851,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,469,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

양전자 방사 단층촬영(PET)용 방사성 트레이서 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2028년 연간 평균 성장률(CAGR)은 9.2%로, 33억 3,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 용도 확대, 규제 당국의 승인, 신흥 시장 성장, 노인 인구 증가, PET 라디오 스캐너 채택 증가 등에 기인합니다. 이 기간 중 주요 동향으로는 마이크로 PET 기술 개발, 웨어러블 기술과의 통합, 테라노스틱스 확대, 나노 방사선 추적기 개발, 데이터 보안을 위한 블록체인 활용 등이 있습니다.

예상되는 감염성 질환 증가는 향후 수년간 양전자방사선단층촬영(PET)용 방사성동위원소 시장의 성장을 가속할 것으로 예측됩니다. 감염성 질환은 박테리아, 바이러스, 곰팡이, 기생충과 같은 병원성 미생물에 의해 유발되는 질병입니다. 이러한 질병의 확산을 촉진하는 요인으로는 기후 변화, 도시화, 세계화, 항생제 내성, 인간 행동의 변화 등이 있으며, 이러한 요인들은 모두 병원균의 확산을 촉진하고 있습니다. 감염을 감지하고, 치료 반응을 평가하고, 감염과 비감염을 구분하여 궁극적으로 환자의 예후를 개선하는 데 도움을 줄 수 있습니다. 예를 들어 2024년 2월 영국 정부 기관인 UK Health Security Agency의 보고서에 따르면 영국내 결핵 환자 수는 2023년 10.7% 증가하여 2022년 4,380명에 비해 4,850명으로 보고되었습니다. 따라서 전염병의 확산은 PET 방사성 추적기 시장에 대한 수요를 촉진하고 있습니다.

PET 방사성 추적자 시장의 주요 기업은 암의 검출을 개선하고 환자의 예후를 개선하는 PET 이미징 제제와 같은 고급 진단 솔루션 개발에 주력하고 있으며, PET 이미징 제제는 PET 스캔 중에 체내의 생물학적 과정을 시각화하고 측정하는 데 활용되는 방사성 물질입니다. 예를 들어 2023년 3월 캐나다의 방사성 의약품 회사인 IsoLogic Innovative Radiopharmaceuticals는 전이성 전립선암을 검출하기 위한 전립선암 영상 진단용 약물인 Ga-68 Gozetotide Preparation Kit(PSMA-11)로도 알려진 Illuccix를 캐나다에서 출시했습니다. 이 툴은 의사가 전이성 질환을 식별하고 환자의 관리 방침을 결정하는 데 매우 중요한 역할을 합니다. 전이가 의심되고 1차 확정 치료의 적응증이 있는 환자, 혈청 전립선특이항원(PSA) 수치 상승으로 재발이 의심되는 환자들에게 적용됩니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

• 고인플레이션이 시장에 미치는 영향
• 우크라이나·러시아 전쟁이 시장에 미치는 영향
• 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

• 세계의 양전자 방사 단층촬영(PET)용 방사성 트레이서 시장 : 촉진요인과 억제요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
• 세계의 양전자 방사 단층촬영(PET)용 방사성 트레이서 시장 실적 : 규모와 성장, 2018-2023년
• 세계의 양전자 방사 단층촬영(PET)용 방사성 트레이서 시장 예측 : 규모와 성장, 2023-2028년, 2033년

제6장 시장 세분화

• 세계의 양전자 방사 단층촬영(PET)용 방사성 트레이서 시장 : 방사성 트레이서 유형별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• F-18(Fluorodeoxyglucose 18)
• Ga-68(섬유아세포 활성화 단백질 저해제)
• 기타
• 세계의 양전자 방사 단층촬영(PET)용 방사성 트레이서 시장 : 용도별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• 암
• 심장병
• 위장
• 내분비
• 신경질환
• 기타
• 세계의 양전자 방사 단층촬영(PET)용 방사성 트레이서 시장 : 최종사용자별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• 병원
• 진단 센터
• 기타

제7장 지역별·국가별 분석

• 세계의 양전자 방사 단층촬영(PET)용 방사성 트레이서 시장 : 지역별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• 세계의 양전자 방사 단층촬영(PET)용 방사성 트레이서 시장 : 국가별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 양전자 방사 단층촬영(PET)용 방사성 트레이서 시장 : 경쟁 구도
• 양전자 방사 단층촬영(PET)용 방사성 트레이서 시장 : 기업 개요
  • Cardinal Health Inc.
  • AstraZeneca PLC
  • Eli Lilly and Company
  • Siemens Healthineers AG
  • GE Healthcare Technologies Inc.

제31장 기타 대기업과 혁신적 기업

• Philips Healthcare
• Bracco Imaging S.p.A.
• Neusoft Medical Systems Co Ltd.
• Lantheus Holdings Inc.
• Jubilant Pharma Limited
• SOFIE Biosciences(SOFIE)
• Yantai Dongcheng Pharmaceutical Group Co. Ltd.
• Nordion Inc.
• RefleXion Medical Inc.
• Isologic Innovative Radiopharmaceuticals
• ABX Advanced Biochemical Compounds GmbH
• IBA Radiopharma Solutions S.A.
• IXICO PLC
• ImaginAb Inc.
• Radiomedix Inc.

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 합병과 인수

제35장 향후 전망과 잠재적 분석

제36장 부록

KSA

영문 목차

영문목차

A positron emission tomography (PET) radiotracer is a radioactive substance used in PET imaging. This radiotracer is administered to a patient via injection, where it binds to specific biological targets, enabling the PET scanner to visualize metabolic activity and diagnose conditions such as cancer or neurological disorders.

The primary types of PET radiotracers include F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), and others. F-18 (Fluorodeoxyglucose 18) radiotracers are radioactive glucose analogs utilized in PET imaging to evaluate metabolic activity in tissues, particularly for cancer detection. These radiotracers are applied across various medical fields, including oncology, cardiology, gastrointestinal disorders, endocrine issues, and neurology. They are used by end-users such as hospitals and diagnostic centers, among others.

The positron emission tomography (PET) radiotracer market research report is one of a series of new reports from The Business Research Company that provides positron emission tomography (PET) radiotracer market statistics, including the positron emission tomography (PET) radiotracer industry's global market size, regional shares, competitors with a positron emission tomography (PET) radiotracer market share, detailed positron emission tomography (PET) radiotracer market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (PET) radiotracer industry. This positron emission tomography (PET) radiotracer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The positron emission tomography (PET) radiotracer market size has grown strongly in recent years. It will grow from $2.15 billion in 2023 to $2.35 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth during the historic period can be attributed to the rising prevalence of infectious diseases, greater awareness and accessibility of healthcare, the emergence of novel radiotracers, the increasing incidence of cancer, and a heightened focus on preventive medicine.

The positron emission tomography (PET) radiotracer market size is expected to see strong growth in the next few years. It will grow to $3.33 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The anticipated growth during the forecast period can be attributed to the expansion of applications, regulatory approvals, growth in emerging markets, an increasing geriatric population, and the rising adoption of PET radio scanners. Key trends during this period include the development of micro-PET technology, integration with wearable technology, expansion of theranostics, advancements in nano-radiotracers, and the use of blockchain for data security.

The anticipated rise in infectious diseases is projected to drive the growth of the positron emission tomography (PET) radiotracer market in the coming years. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites. Factors contributing to the increased prevalence of these diseases include climate change, urbanization, globalization, antibiotic resistance, and shifts in human behavior, all of which facilitate the spread of pathogens. PET radiotracers play a crucial role in managing infectious diseases by visualizing metabolic activity and inflammation, which aids in the detection of infections, assessment of treatment responses, and differentiation between infectious and non-infectious conditions, ultimately leading to improved patient outcomes. For example, in February 2024, a report from the UK Health Security Agency, a government agency in the UK, indicated that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Hence, the growing prevalence of infectious diseases is driving demand for the PET radiotracer market.

Leading companies in the PET radiotracer market are concentrating on developing advanced diagnostic solutions, such as PET imaging agents that improve cancer detection and enhance patient outcomes. A PET imaging agent is a radioactive substance utilized to visualize and measure biological processes in the body during PET scans. For instance, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a Canadian radiopharmaceutical firm, launched Illuccix, also known as the Ga-68 Gozetotide Preparation Kit (PSMA-11), in Canada as a prostate cancer imaging agent aimed at detecting metastatic prostate cancer. This tool is crucial for physicians in identifying metastatic disease and making informed patient management decisions. It is indicated for patients suspected of metastasis who are candidates for initial definitive therapy, as well as for those with suspected recurrence indicated by elevated serum prostate-specific antigen (PSA) levels.

In February 2023, Lantheus Holdings Inc., a U.S.-based developer of diagnostic products, acquired Cerveau Technologies for an undisclosed sum. This acquisition is intended to enhance Lantheus Holdings' imaging pipeline, particularly for Alzheimer's disease diagnostics, by integrating Cerveau's MK-6240, a second-generation PET imaging agent that targets tau tangles in the brain. Cerveau Technologies Inc. is a U.S.-based provider of information and technology specializing in PET radiotracers.

Major companies operating in the positron emission tomography (PET) radiotracer market are Cardinal Health Inc., AstraZeneca PLC, Eli Lilly and Company, Siemens Healthineers AG, GE Healthcare Technologies Inc., Philips Healthcare, Bracco Imaging S.p.A., Neusoft Medical Systems Co Ltd., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences (SOFIE), Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., RefleXion Medical Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., IXICO PLC, ImaginAb Inc., Radiomedix Inc.

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the positron emission tomography (PET) radiotracer marker report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The positron emission tomography (PET) radiotracer market consists of sales of FDG (fluorodeoxyglucose), f-dopa (fluorodopa), C-11 methionine, C-11 methionine, F-18 naf (sodium fluoride), and C-11 choline. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Positron Emission Tomography (PET) Radiotracer Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on positron emission tomography (PET) radiotracer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for positron emission tomography (PET) radiotracer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The positron emission tomography (PET) radiotracer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18); Ga-68 (Fibroblast Activation Protein Inhibitor); Other Radiotracer Types
• 2) By Application: Cancer; Heart Disease; Gastrointestinal; Endocrine; Neurological Disorders; Other Applications
• 3) By End-User: Hospitals; Diagnostic Centers; Other End-Users
• Companies Mentioned: Cardinal Health Inc.; AstraZeneca PLC; Eli Lilly and Company; Siemens Healthineers AG; GE Healthcare Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Positron Emission Tomography (PET) Radiotracer Market Characteristics

3. Positron Emission Tomography (PET) Radiotracer Market Trends And Strategies

4. Positron Emission Tomography (PET) Radiotracer Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Positron Emission Tomography (PET) Radiotracer Market Size and Growth

• 5.1. Global Positron Emission Tomography (PET) Radiotracer Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Positron Emission Tomography (PET) Radiotracer Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Positron Emission Tomography (PET) Radiotracer Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Positron Emission Tomography (PET) Radiotracer Market Segmentation

• 6.1. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• F-18 (Fluorodeoxyglucose 18)
• Ga-68 (Fibroblast Activation Protein Inhibitor)
• Other Radiotracer Types
• 6.2. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cancer
• Heart Disease
• Gastrointestinal
• Endocrine
• Neurological Disorders
• Other Applications
• 6.3. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Diagnostic Centers
• Other End-Users

7. Positron Emission Tomography (PET) Radiotracer Market Regional And Country Analysis

• 7.1. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market

• 8.1. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Positron Emission Tomography (PET) Radiotracer Market

• 9.1. China Positron Emission Tomography (PET) Radiotracer Market Overview
• 9.2. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Positron Emission Tomography (PET) Radiotracer Market

• 10.1. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Positron Emission Tomography (PET) Radiotracer Market

• 11.1. Japan Positron Emission Tomography (PET) Radiotracer Market Overview
• 11.2. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Positron Emission Tomography (PET) Radiotracer Market

• 12.1. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Positron Emission Tomography (PET) Radiotracer Market

• 13.1. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Positron Emission Tomography (PET) Radiotracer Market

• 14.1. South Korea Positron Emission Tomography (PET) Radiotracer Market Overview
• 14.2. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Positron Emission Tomography (PET) Radiotracer Market

• 15.1. Western Europe Positron Emission Tomography (PET) Radiotracer Market Overview
• 15.2. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Positron Emission Tomography (PET) Radiotracer Market

• 16.1. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Positron Emission Tomography (PET) Radiotracer Market

• 17.1. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Positron Emission Tomography (PET) Radiotracer Market

• 18.1. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Positron Emission Tomography (PET) Radiotracer Market

• 19.1. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Positron Emission Tomography (PET) Radiotracer Market

• 20.1. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market

• 21.1. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market Overview
• 21.2. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Positron Emission Tomography (PET) Radiotracer Market

• 22.1. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Positron Emission Tomography (PET) Radiotracer Market

• 23.1. North America Positron Emission Tomography (PET) Radiotracer Market Overview
• 23.2. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Positron Emission Tomography (PET) Radiotracer Market

• 24.1. USA Positron Emission Tomography (PET) Radiotracer Market Overview
• 24.2. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Positron Emission Tomography (PET) Radiotracer Market

• 25.1. Canada Positron Emission Tomography (PET) Radiotracer Market Overview
• 25.2. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Positron Emission Tomography (PET) Radiotracer Market

• 26.1. South America Positron Emission Tomography (PET) Radiotracer Market Overview
• 26.2. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Positron Emission Tomography (PET) Radiotracer Market

• 27.1. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Positron Emission Tomography (PET) Radiotracer Market

• 28.1. Middle East Positron Emission Tomography (PET) Radiotracer Market Overview
• 28.2. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Positron Emission Tomography (PET) Radiotracer Market

• 29.1. Africa Positron Emission Tomography (PET) Radiotracer Market Overview
• 29.2. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape And Company Profiles

• 30.1. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape
• 30.2. Positron Emission Tomography (PET) Radiotracer Market Company Profiles
  • 30.2.1. Cardinal Health Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. AstraZeneca PLC
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Eli Lilly and Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Siemens Healthineers AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. GE Healthcare Technologies Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Positron Emission Tomography (PET) Radiotracer Market Other Major And Innovative Companies

• 31.1. Philips Healthcare
• 31.2. Bracco Imaging S.p.A.
• 31.3. Neusoft Medical Systems Co Ltd.
• 31.4. Lantheus Holdings Inc.
• 31.5. Jubilant Pharma Limited
• 31.6. SOFIE Biosciences (SOFIE)
• 31.7. Yantai Dongcheng Pharmaceutical Group Co. Ltd.
• 31.8. Nordion Inc.
• 31.9. RefleXion Medical Inc.
• 31.10. Isologic Innovative Radiopharmaceuticals
• 31.11. ABX Advanced Biochemical Compounds GmbH
• 31.12. IBA Radiopharma Solutions S.A.
• 31.13. IXICO PLC
• 31.14. ImaginAb Inc.
• 31.15. Radiomedix Inc.

32. Global Positron Emission Tomography (PET) Radiotracer Market Competitive Benchmarking

33. Global Positron Emission Tomography (PET) Radiotracer Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Positron Emission Tomography (PET) Radiotracer Market

35. Positron Emission Tomography (PET) Radiotracer Market Future Outlook and Potential Analysis

• 35.1 Positron Emission Tomography (PET) Radiotracer Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Positron Emission Tomography (PET) Radiotracer Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Positron Emission Tomography (PET) Radiotracer Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료